We know where we stand against many of the big dogs. Brilacidin just needs to get to the P3 starting gate with a protocol meant to impress.
And yes, if B beats once again, hands down, IPIX on top with all the insurance companies and doctors.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
-
-
-
-
-
-
-